Kane Biotech Inc Ord (KNBIF) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and thank you for standing by. Welcome to Kean Biotech's fourth quarter and full year 2023 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be open to questions. If you have a question, please press star 1-1 on your touchtone phone. If you'd like to withdraw your question, please press star 1-1 again. This conference is being recorded today, March 26, 2024. I would like to turn the conference call over to Ray Dupuy, Kean Biotech's Chief Financial Officer. Please go ahead. Thank you, Operator. Good afternoon and welcome, everyone, to Kean Biotech's fourth quarter and full year 2023 earnings conference call. We are delighted to have you join us today. This call will cover Kean's financial and operating results, along with a discussion of some of our recent highlights and goals for 2024 and beyond. Following our prepared remarks, we will open the conference call to a question and answer session. Our call today will be led by King's chief executive officer, Mark Edwards. Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward-looking information and statements within the meaning of securities law, which may not be based on historical fact, including without limitation statements containing the words believes, should, may, plan, will, estimate, predict, continue, anticipate, potential, intends, expects, or other similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, events, or developments to be materially different from any future results, events, or developments expresse...